• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Panbela Therapeutics, Inc. - Common Stock (NQ:PBLA)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Mar 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 1.020 (5)
Ask (Size) 1.040 (1)
Prev. Close 1.110
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 5,127,686
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
PBLA Stock Earnings: Panbela Therapeutics Misses EPS for Q1 2024 ↗
May 15, 2024
PBLA stock results show that Panbela Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac
May 06, 2024
Developed in collaboration with Sanofi. 
From Panbela Therapeutics, Inc.
Via GlobeNewswire

Performance

More News

Read More
News headline image
Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024
May 01, 2024
From Panbela Therapeutics, Inc.
Via GlobeNewswire
News headline image
Recap: Panbela Therapeutics Q4 Earnings ↗
March 26, 2024
Via Benzinga
News headline image
Earnings Preview: Panbela Therapeutics ↗
March 25, 2024
Via Benzinga
News headline image
Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week
April 30, 2024
From Panbela Therapeutics, Inc.
Via GlobeNewswire
News headline image
Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025
April 22, 2024
From Panbela Therapeutics, Inc.
Via GlobeNewswire
News headline image
Panbela Announces Poster Presentation at American Association for Cancer Research:
April 18, 2024
From Panbela Therapeutics, Inc.
Via GlobeNewswire
News headline image
Panbela Announces Transfer to OTCQB Market
April 16, 2024
From Panbela Therapeutics, Inc.
Via GlobeNewswire
News headline image
PBLA Stock Earnings: Panbela Therapeutics Misses EPS for Q4 2023 ↗
March 26, 2024
Via InvestorPlace
News headline image
Panbela to Host Fourth Quarter and Year End 2023 Earnings Conference Call on March 26, 2024
March 12, 2024
From Panbela Therapeutics, Inc.
Via GlobeNewswire
News headline image
Top 4 Health Care Stocks That Are Preparing To Pump This Month ↗
February 23, 2024
Via Benzinga
News headline image
Panbela Regains Compliance with Nasdaq Listing Standards for Bid Price and Publicly Held Shares Requirements
February 15, 2024
From Panbela Therapeutics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
February 14, 2024
Via Benzinga
BioMedNewsBreaks – Panbela Therapeutics Inc. (NASDAQ: PBLA) Secures ~$9M in Public Offering
February 01, 2024
Via Investor Brand Network
News headline image
Panbela Announces Closing of Approximately $9.0 Million Public Offering
February 01, 2024
From Panbela Therapeutics, Inc.
Via GlobeNewswire
News headline image
What's Going On With Panbela Therapeutics Stock Today? ↗
January 30, 2024
Via Benzinga
News headline image
Acceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR)
January 30, 2024
From Panbela Therapeutics, Inc.
Via GlobeNewswire
News headline image
Crude Oil Down Over 1%; Science 37 Holdings Shares Spike Higher ↗
January 29, 2024
Via Benzinga
Topics Stocks
News headline image
Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
January 29, 2024
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
January 29, 2024
Via Benzinga
News headline image
Dow Edges Lower; Cardlytics Shares Jump ↗
January 29, 2024
Via Benzinga
Topics Stocks
News headline image
US Stocks Edge Higher; Amazon And iRobot Agree To Terminate Acquisition Deal ↗
January 29, 2024
Via Benzinga
Topics Stocks
News headline image
Why Is Aclarion (ACON) Stock Down 16% Today? ↗
January 29, 2024
Via InvestorPlace
News headline image
Why Is Panbela Therapeutics (PBLA) Stock Down 63% Today? ↗
January 29, 2024
Via InvestorPlace

Frequently Asked Questions

Is Panbela Therapeutics, Inc. - Common Stock publicly traded?
Yes, Panbela Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Panbela Therapeutics, Inc. - Common Stock trade on?
Panbela Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Panbela Therapeutics, Inc. - Common Stock?
The ticker symbol for Panbela Therapeutics, Inc. - Common Stock is PBLA on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap